CD8+ T cell effectors against microsporidia

对抗微孢子虫的 CD8 T 细胞效应

基本信息

  • 批准号:
    8532815
  • 负责人:
  • 金额:
    $ 37.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-17 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Microsporidial infection continues to be a problem for HIV infected individuals and are associated as a cause of persistent diarrhea and systemic disease in these people. Recent studies have also implicated these agents in causing illness to HIV- negative groups like travelers and immuno-competent elderly individuals. The limited studies available with Encephalitozoon cuniculi, a microsporidia that can be easily cultured in the laboratory have demonstrated importance of T cells in protection against the parasite. Amongst the T cell subsets, CD8+ T lymphocytes are primary effector cells responsible for protective immunity with CD4+ and ?¿ T playing an important helper role. Knock out animals lacking either of the two subsets exhibit sub-optimal CD8+ T cell immunity to E.cuniculi infection. Recent studies from our laboratory suggest that IL- 21, a cytokine produced by both CD4 and ?¿ T cells, is important for the induction of multifunctional CD8+T cell response against the pathogen. Neutralization of IL-21 response leads to decreased polyfunctional and increased mono-functional CD8+ T cell response as a result of which they are less protective and the host is unable to clear infection in an efficient manner. Importance of poly or multifunctional CD8+ T cells has recently been associated with increased protection against viral pathogens, although the direct link has yet to established. Thus it appears that IL-21 mediated polyfunctional CD8+ T cell response is key to protection against E.cuniculi infection which poses a risk to HIV infected population. The proposal comprises of three specific aims. In the first specific aim the kinetics o IL-21 response by ?¿ and CD4+ T cell population in response to E.cuniculi infection will be evaluated. The mechanism of IL-21 production and priming of CD8+ T cell response against the pathogen will be assayed. In the second specific aim role of IL-21 in the development of polyfunctional CD8+ T cell effector response will be determined. Further, importance of polyfunctionality in the development of robust long-term response will be analyzed. In the third and final specific aim various strategies which can lead to induction and maintenance of polyfunctional CD8+ T cell response in immunocompromised (like HIV-infected) host will be tested and therapeutic role of IL-21 in this situation will be evaluated. These studies will have fr reaching implications in other opportunistic infections and viral pathogens where development of robust CD8+ T cell response is critical for host protection.
描述(通过应用程序证明):在这些人和免疫能力的老年人中,微观物质侵蚀仍然是腹泻和全身性疾病。 。 t在我们的实验室中扮演重要的研究。 T细胞,多功能CD8+ T细胞反应的t-Cells对病原体的响应,并增加了单官能CD8+ T细胞反应,因此较少的保护和宿主无法清除效率直接链接尚未建立的响应。 CD4+ T细胞群体对E.Cuniculi的响应将评估IL-21的产生机理,而CD8+ T细胞反应Ag的启动将在病原体中分析IL-21的第二个特定目标。多功能CD8+ T细胞效应器进一步恢复。将对HIV感染的宿主进行测试,并在其他其他病毒病原体中评估IL-21的治疗作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IMTIAZ AHMED KHAN其他文献

IMTIAZ AHMED KHAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IMTIAZ AHMED KHAN', 18)}}的其他基金

CD4 dysfunction and cerebral toxoplasmosis
CD4功能障碍与脑弓形体病
  • 批准号:
    10403626
  • 财政年份:
    2020
  • 资助金额:
    $ 37.53万
  • 项目类别:
CD4 dysfunction and cerebral toxoplasmosis
CD4功能障碍与脑弓形体病
  • 批准号:
    10194373
  • 财政年份:
    2020
  • 资助金额:
    $ 37.53万
  • 项目类别:
CD4 dysfunction and cerebral toxoplasmosis
CD4功能障碍与脑弓形体病
  • 批准号:
    10028307
  • 财政年份:
    2020
  • 资助金额:
    $ 37.53万
  • 项目类别:
miR146a and CD4 dysfunction during chronic toxoplasmosis
慢性弓形虫病期间 miR146a 和 CD4 功能障碍
  • 批准号:
    9435967
  • 财政年份:
    2018
  • 资助金额:
    $ 37.53万
  • 项目类别:
CD8+ T Cell exhaustion during Toxoplasmosis
弓形虫病期间 CD8 T 细胞耗竭
  • 批准号:
    8896135
  • 财政年份:
    2014
  • 资助金额:
    $ 37.53万
  • 项目类别:
IL-21 dependent immunity to microsporidia
对微孢子虫的 IL-21 依赖性免疫
  • 批准号:
    8698505
  • 财政年份:
    2013
  • 资助金额:
    $ 37.53万
  • 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
  • 批准号:
    8329808
  • 财政年份:
    2012
  • 资助金额:
    $ 37.53万
  • 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
  • 批准号:
    8700315
  • 财政年份:
    2012
  • 资助金额:
    $ 37.53万
  • 项目类别:
CD8+ T cell effectors against microsporidia
对抗微孢子虫的 CD8 T 细胞效应
  • 批准号:
    8892976
  • 财政年份:
    2012
  • 资助金额:
    $ 37.53万
  • 项目类别:
Dendritic Cell Response to Microsporidians
树突状细胞对微孢子虫的反应
  • 批准号:
    7245888
  • 财政年份:
    2006
  • 资助金额:
    $ 37.53万
  • 项目类别:

相似海外基金

Enhancing HIV assisted contact tracing in Malawi through blended learning: An Implementation Science Study
通过混合学习加强马拉维艾滋病毒辅助接触者追踪:一项实施科学研究
  • 批准号:
    10082594
  • 财政年份:
    2020
  • 资助金额:
    $ 37.53万
  • 项目类别:
Enhancing HIV assisted contact tracing in Malawi through blended learning: An Implementation Science Study
通过混合学习加强马拉维艾滋病毒辅助接触者追踪:一项实施科学研究
  • 批准号:
    10222533
  • 财政年份:
    2020
  • 资助金额:
    $ 37.53万
  • 项目类别:
MASLIHAT Intervention for Tajik Male Migrants Who Inject Drugs
MASLIHAT 对注射毒品的塔吉克男性移民的干预
  • 批准号:
    10217085
  • 财政年份:
    2020
  • 资助金额:
    $ 37.53万
  • 项目类别:
Establishing a Platform for Clinical Improvement for Children with HIV-Associated Malignancies in Sub-Saharan Africa
为撒哈拉以南非洲地区患有艾滋病毒相关恶性肿瘤的儿童建立临床改进平台
  • 批准号:
    10223903
  • 财政年份:
    2020
  • 资助金额:
    $ 37.53万
  • 项目类别:
MASLIHAT Intervention for Tajik Male Migrants Who Inject Drugs
MASLIHAT 对注射毒品的塔吉克男性移民的干预
  • 批准号:
    10401872
  • 财政年份:
    2020
  • 资助金额:
    $ 37.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了